课题基金 / 基金详情

Effect of inhaled volatile anesthetics on ATP-signal transduction system

Effect of inhaled volatile anesthetics on ATP-signal transduction system
吸入挥发性麻醉药对 ATP 信号转导系统的影响
批准号:
11671525
负责人:
MASAKI Eiji
金额:
$2.43万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2002

项目摘要

项目成果

MASAKI Eiji的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study was undertaken to examine the effects of volatile anesthetics (VA) on ATP signaltransduction system and clarify the involvement of this system in sites and mechanisms of the anesthetics. The experiments were performed both in vivo and in vitro as following.I. In vivo. 1) Effects of the intracerebroventricular (ICV) administration of P2 antagonits on the minimum alveolar concentration (MAC) of VA in rats. 2) The anesthetic interaction between ATP and NMDA receptor agonists in the rats.II. In vitro. 3) Effects of VA on the ATP binding to P2X receptor in the rat brain crude synaptic membrane. 4) Effects of sevoflurane on the ATP-activated inward current in locus coeruleus neurons in pontine slices of rats. 5) Effects of sevoflurane on the recombirtant P2X receptors expressed in HEK 293 cells.Results: I. In vivo. 1) ICV administration of P2 antagonist decreased the MAC of sevoflurane and isoflurane. 2) The effects of coadministration of both ATP and NMDA receptor antagonists was additive in the reduction of sevoflurane MAC.II. In vitro. 3) VA did not affect the ATP binding to P2X receptor. 4) ATP-activated inward current in locus coeruleus neurons was dose-dependentiy reduced by s-evoflurane. 5) The inward currents through P2X2 and P2X4 receptors were suppressed by sevoflurane in raft but not isolated cells.These results suggest that inhibition of ATP signal transduction system is, at least in part, involved in the site and mechanism of VA's mode of action. Furthermore, suppression of signaling through gap junction is also implicated with the site and mechanism of action of VA.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
E. Masaki et. al.: "The [^3H]α,β-methylene ATP binding to P2X purinoceptor is not affected by volatile anesthetics"European Journal of Anaesthesiology. in press.
E. Masaki 等人:“[^3H]α,β-亚甲基 ATP 与 P2X 嘌呤受体的结合不受挥发性麻醉剂的影响”《欧洲麻醉学杂志》正在出版。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Nishi et al.: "ADP-sensitive purinoceptors induce steroidogensis via adenylyl cyclase activation in bovine adrenocortical fasciculata cells"British Journal of Pharmacology. 137. 177-184 (2002)
H.Nishi等人:“ADP敏感性嘌呤受体通过牛肾上腺皮质束状细胞中的腺苷酸环化酶激活诱导类固醇生成”英国药理学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E.Masaki et al.: "The [^3H] a, a-methylene ATP binding to P2X purinoceptor is not affected by volatile anesthetics"European Journal of Anaesthesiology. (in press). (2003)
E.Masaki 等人:“与 P2X 嘌呤受体结合的 [^3H]a,a-亚甲基 ATP 不受挥发性麻醉剂的影响”《欧洲麻醉学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E.Masaki et al.: "The anesthetic interaction between adenosine triphosphate and N-methyl-D-aspartate receptor antagonists in the rats"Anesthesia and Analgesia. 92. 134-139 (2001)
E.Masaki 等人:“大鼠中三磷酸腺苷和 N-甲基-D-天冬氨酸受体拮抗剂之间的麻醉相互作用”麻醉和镇痛。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Challenging of new therapeutic modalities for pain management with narcotic pro-drug.
    • 批准号:
      22659362
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.07万
    • 财政年份:
      2010
    • 负责人:
      MASAKI Eiji
    • 依托单位:
    The pain regulatory system in CNS, and ideal anesthetic and pain managements
    • 批准号:
      18591720
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.17万
    • 财政年份:
      2006
    • 负责人:
      MASAKI Eiji
    • 依托单位:
    Effects of halogenated inhalated anesthetics on nitric oxide (NO) signal transduction system.
    • 批准号:
      06454452
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $2.62万
    • 财政年份:
      1994
    • 负责人:
      MASAKI Eiji
    • 依托单位: